(63 days)
Not Found
No
The device description and intended use are for a physical implant (femoral heads) and do not mention any software, algorithms, or data processing capabilities that would indicate the use of AI/ML. The "Mentions AI, DNN, or ML" and "Mentions image processing" sections are explicitly marked as "Not Found".
Yes
The device is a femoral head used in total hip arthroplasty to treat severely painful and disabled joints, which directly aims to alleviate a medical condition.
No
The device is a Co-Cr-Mo alloy femoral head intended for use in total hip arthroplasty, which is a surgical procedure to replace a hip joint. It is a prosthetic implant, not a tool for diagnosing medical conditions.
No
The device description clearly states it is a Co-Cr-Mo alloy femoral head, which is a physical implant, not software.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to perform tests on samples taken from the human body (like blood, urine, tissue) to provide information about a person's health.
- Device Description and Intended Use: The provided text clearly describes a physical implant (femoral heads) intended for surgical implantation in the hip joint to treat various conditions. It is a prosthetic device used in vivo (within the living body), not a device used to test samples in vitro (outside the living body).
The information provided aligns with a description of a surgical implant, not an IVD.
N/A
Intended Use / Indications for Use
The Articul/eze Femoral Heads are intended to be used with DePuy femoral hip stems with Articul/eze male tapers in cemented or cementless total hip arthroplasty for the indications of: a severely painful and/or severely disabled joint resulting from osteoarthritis, or rheumatoid arthritis; avascular necrosis of the femoral head; acute traumatic fracture of the femoral head or neck; a failed previous surgery, including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or other total hip replacement; and certain cases of ankylosis.
Product codes (comma separated list FDA assigned to the subject device)
87 JDI, 87 LPH
Device Description
The subject Articul/eze Femoral Heads are Co-Cr-Mo alloy femoral heads available in: a 22.225mm diameter with +4 and +7 neck lengths: a 26mm diameter with +4, +7 and +10mm neck lengths and a 36mm diameter with -2, +1.5, +5, +8.5 and +12mm neck lengths. All of the Articul/eze taper femoral heads have an internal 5°43' taper which mates with the 5°40' external taper on DePuy Articul/eze taper femoral stems.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Femoral head, Hip joint
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3350 Hip joint metal/polymer semi-constrained cemented prosthesis.
(a)
Identification. A hip joint metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a hip joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and an acetabular resurfacing component made of ultra-high molecular weight polyethylene and is limited to those prostheses intended for use with bone cement (§ 888.3027).(b)
Classification. Class II.
0
K980513
SUMMARY OF SAFETY AND EFFECTIVENESS
APR | 4 1998
| NAME OF FIRM: | DePuy Inc. |
|---|---|
| P.O. Box 988 | |
| 700 Orthopaedic Drive | |
| Warsaw, Indiana 46581-0988 | |
| 510(k) CONTACT: | Cheryl Hastings |
| Manager, Regulatory Submissions | |
| TRADE NAME: | Articul/eze Femoral Heads |
| COMMON NAME: | Femoral Heads |
| CLASSIFICATIONS: | 888.3350: Hip joint metal/polymer semi-constrained cemented prosthesis |
| 888.3358: Hip joint metal/polymer/metal semi-constrained porous-coated uncemented prosthesis | |
| DEVICE PRODUCT CODES: | 87 JDI and 87 LPH |
SUBSTANTIALLY DePuy Focus Total Hip System (K883460) EQUIVALENT DEVICES: DePuy Zirconia Articul/eze Femoral Balls (K952088)
DEVICE DESCRIPTION AND INTENDED USE:
The subject Articul/eze Femoral Heads are Co-Cr-Mo alloy femoral heads available in: a 22.225mm diameter with +4 and +7 neck lengths: a 26mm diameter with +4, +7 and +10mm neck lengths and a 36mm diameter with -2, +1.5, +5, +8.5 and +12mm neck lengths. All of the Articul/eze taper femoral heads have an internal 5°43' taper which mates with the 5°40' external taper on DePuy Articul/eze taper femoral stems.
The Articul/eze Femoral Heads are intended to be used with DePuv femoral hip stems with Articul/eze male tapers in cemented or cementless total hip arthroplasty for the indications of: a severely painful and/or severely disabled joint resulting from osteoarthritis, or rheumatoid arthritis; avascular necrosis of the femoral head; acute traumatic fracture of the femoral head or neck; a failed previous surgery, including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or other total hip replacement; and certain cases of ankylosis.
BASIS OF SUBSTANTIAL EQUIVALENCE:
The listed substantially equivalent predicate device 510(k)s include Articul/eze taper cobalt-chrome alloy femoral heads in 28 and 32mm diameters and zirconia femoral heads in 26, 28 and 32mm diameters. The subject 22.225mm, 26mm and 36mm diameter Articul/eze taper cobalt-chrome femoral heads are being added to this line to give the surgeon a larger range of size and material options from which to select the best femoral head replacement for each patient. Based on similarities of design, material and intended use, DePuy believes that the subject Articul/eze Femoral Heads are substantially equivalent to the above listed predicate devices.
UOTHING
1
Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized image of an eagle with three lines representing its wings and body.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
APR 1 4 1998
Ms. Cheryl Hastings Manager, Regulatory Submissions DePuy Orthopaedics, Inc. P.O. Box 988 700 Orthopaedic Drive Warsaw, Indiana 46581-0988
K980513 Re: Articul/eze Femoral Heads Trade Name: Regulatory Class: II Product Code: JDI and LPH February 6, 1998 Dated: February 10, 1998 Received:
Dear Ms. Hastings:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions The general controls provisions of the Act of the Act. include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A . . . substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP requlation may result in regulatory In addition, FDA may publish further announcements action. concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
2
Page 2 - Ms. Cheryl Hastings
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to
premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Stephen Rhodes
Celia M. Witten, Ph.D., M.D.
Director
Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
3
510(k) Number (if known)_ K9 & S/3
Device Name DePuy Orthopaedics Articul/eze Femoral Heads
Indications for Use:
The Articul/eze Femoral Heads are intended to be used with DePuy femoral hip stems with Articul/eze (12/14mm) male tapers in cementless total hip arthroplasty for the indications of: a severely painful and/or severely disabled joint resulting from osteoarthritis, traumatic arthritis, or rheumatoid arthritis; avascular necrosis of the femoral head; acute traumatic fracture of the femoral head or neck; a failed previous surgery, including joint reconstruction, internal fixation, arthrodesis, hemiarthroplasty, surface replacement arthroplasty, or other total hip replacement; and certain cases of ankylosis.
Concurrence of CDRH, Office of Device Evaluation
Stato Rhodes
(Division Sign-Off) (Division Sign-Off)
Division of General Restorative Device
510(k) Number
OR
Prescription Use
(Per 21 CFR 801.109)
Over-The-Counter Use